Results 311 to 320 of about 250,918 (350)

Whole‐genome CRISPR‐Cas9 knockout screens identify SHOC2 as a genetic dependency in NRAS‐mutant melanoma

Cancer Communications, EarlyView.
Andrea Y. Gu, Tet Woo Lee, Aziza Khan, Xuenan Zhang, Francis W. Hunter, Dean C. Singleton, Stephen M. F. Jamieson   +6 more
wiley   +1 more source

Methods for Controlling Small GTPase Activity

ChemBioChem, Accepted Article.
Small GTPases comprise a diverse class of signaling proteins in mammalian cells and regulate a variety of cellular processes such as cell growth, cell movement, vesicle formation, and nuclear transport. Due to their involvement in critical cellular pathways, changes in the activation state of small GTPases due to genetic mutations or alterations in ...
Benjamin Faulkner, Yuchen He, Daniel Sitrin, Cliff Stains   +3 more
wiley   +1 more source

Molecular Interplay Between Non-Coding RNAs and Connexins and Its Possible Role in Cancer. [PDF]

Int J Mol Sci
Pérez-Moreno P, Muñoz JP, Retamal MA.
europepmc   +1 more source

Targeted reactivation of the novel tumor suppressor DAPK1, an upstream regulator of p53, in high‐grade serous ovarian cancer by mRNA liposomes reduces viability and enhances drug sensitivity in preclinical models

Cancer Communications, EarlyView.
Monika Raab, Balázs Győrffy, Samuel Peña‐Llopis, Daniela Fietz, Monika Kressin, Margareta Kolaric, Matthias Ebert, Khayal Gasimli, Sven Becker, Mourad Sanhaji, Klaus Strebhardt   +10 more
wiley   +1 more source

Complex rearrangements fuel ER⁺ and HER2⁺ breast tumours. [PDF]

Nature
Houlahan KE, Mangiante L, Sotomayor-Vivas C, Adimoelja A, Park S, Khan A, Pribus SJ, Ma Z, Caswell-Jin JL, Curtis C.   +9 more
europepmc   +1 more source

Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross‐over pharmacokinetic drug‐drug interaction study

Cancer Communications, EarlyView.
Niels Heersche, Daan A. C. Lanser, Esther Oomen‐de Hoop, Attila Içli, Peter de Bruijn, Marthe S. Paats, Elisabeth F. C. van Rossum, Stijn L. W. Koolen, Ron H. N. van Schaik, Anne‐Marie C. Dingemans, G. D. Marijn Veerman, Ron H. J. Mathijssen   +11 more
wiley   +1 more source

Evaluation of specific lncRNAs, miRNAs, and mRNAs in different groups of prostate cancer. [PDF]

Bioimpacts
Vahabzadeh G, Pashapour-Yeganeh A, Eini M, Roudbaraki M, Esmati E, Poorkhani A, Khalighfard S, Alizadeh AM.   +7 more
europepmc   +1 more source

Pathological Mechanisms Involved in HIV-Associated Lymphomagenesis: Novel Targeted Therapeutic Approaches. [PDF]

Cells
Straista M, Caccuri F, Arnaut N, Caruso A, Slevin M.   +4 more
europepmc   +1 more source

Pan-Cancer Analysis Identifies a Ras-Related GTPase as a Potential Modulator of Cancer. [PDF]

Int J Mol Sci
Hsueh HY, Gumpper-Fedus K, Poelstra JW, Pitter KL, Cruz-Monserrate Z.   +4 more
europepmc   +1 more source

Targeting Cancer Stemness Using Nanotechnology in a Holistic Approach: A Narrative Review. [PDF]

Pharmaceutics
Mitranovici MI, Caravia LG, Moraru L, Pușcașiu L.   +3 more
europepmc   +1 more source